Pharmacologically raised AMPK activity inhibited growth of HCC cells and xenograft tumors by inducing senescence, autophagy, and apoptosis (Cheng et al., 2014; Hu et al., 2014; Yi et al., 2013; Yu et al., 2014). This evidence concerns the gene PRKAA2 and hepatocellular carcinoma.